• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性(AMD)的流行病学:与心血管疾病表型和脂质因素的关联

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

作者信息

Pennington Katie L, DeAngelis Margaret M

机构信息

Department of Ophthalmology, John A. Moran Eye Center, University of Utah, Salt Lake City, UT USA.

出版信息

Eye Vis (Lond). 2016 Dec 22;3:34. doi: 10.1186/s40662-016-0063-5. eCollection 2016.

DOI:10.1186/s40662-016-0063-5
PMID:28032115
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5178091/
Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in adults over 50 years old. Genetic, epidemiological, and molecular studies are beginning to unravel the intricate mechanisms underlying this complex disease, which implicate the lipid-cholesterol pathway in the pathophysiology of disease development and progression. Many of the genetic and environmental risk factors associated with AMD are also associated with other complex degenerative diseases of advanced age, including cardiovascular disease (CVD). In this review, we present epidemiological findings associating AMD with a variety of lipid pathway genes, cardiovascular phenotypes, and relevant environmental exposures. Despite a number of studies showing significant associations between AMD and these lipid/cardiovascular factors, results have been mixed and as such the relationships among these factors and AMD remain controversial. It is imperative that researchers not only tease out the various contributions of such factors to AMD development but also the connections between AMD and CVD to develop optimal precision medical care for aging adults.

摘要

年龄相关性黄斑变性(AMD)是50岁以上成年人不可逆失明的主要原因。遗传学、流行病学和分子研究开始揭示这种复杂疾病背后的复杂机制,这些机制表明脂质 - 胆固醇途径参与了疾病发生和发展的病理生理学过程。许多与AMD相关的遗传和环境风险因素也与其他老年复杂退行性疾病相关,包括心血管疾病(CVD)。在本综述中,我们展示了将AMD与多种脂质途径基因、心血管表型及相关环境暴露相关联的流行病学研究结果。尽管多项研究表明AMD与这些脂质/心血管因素之间存在显著关联,但结果不一,因此这些因素与AMD之间的关系仍存在争议。研究人员不仅必须梳理出这些因素对AMD发展的各种影响,还需明确AMD与CVD之间的联系,以便为老年人制定最佳的精准医疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e730/5178091/34f372fadeaf/40662_2016_63_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e730/5178091/34f372fadeaf/40662_2016_63_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e730/5178091/34f372fadeaf/40662_2016_63_Fig1_HTML.jpg

相似文献

1
Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.年龄相关性黄斑变性(AMD)的流行病学:与心血管疾病表型和脂质因素的关联
Eye Vis (Lond). 2016 Dec 22;3:34. doi: 10.1186/s40662-016-0063-5. eCollection 2016.
2
Genetic factors of age-related macular degeneration.年龄相关性黄斑变性的遗传因素。
Prog Retin Eye Res. 2004 Mar;23(2):229-49. doi: 10.1016/j.preteyeres.2004.02.001.
3
The Question of a Role for Statins in Age-Related Macular Degeneration.他汀类药物在年龄相关性黄斑变性中的作用问题。
Int J Mol Sci. 2018 Nov 21;19(11):3688. doi: 10.3390/ijms19113688.
4
Age-Related Macular Degeneration and Mortality in the Age-Related Eye Disease Study (AREDS): The Effect of Sex and Time.年龄相关性眼病研究(AREDS)中年龄相关性黄斑变性与死亡率:性别和时间的影响
Ophthalmol Retina. 2017 Jan-Feb;1(1):49-58. doi: 10.1016/j.oret.2016.09.004. Epub 2016 Nov 18.
5
Mechanisms of age-related macular degeneration and therapeutic opportunities.年龄相关性黄斑变性的发病机制及治疗新靶点
J Pathol. 2014 Jan;232(2):151-64. doi: 10.1002/path.4266.
6
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).干性年龄相关性黄斑变性(AMD)小鼠模型的视网膜超微结构。
Prog Retin Eye Res. 2010 May;29(3):169-90. doi: 10.1016/j.preteyeres.2010.02.002. Epub 2010 Mar 3.
7
Age-related macular degeneration.年龄相关性黄斑变性。
Pharmacotherapy. 2013 Aug;33(8):838-55. doi: 10.1002/phar.1264. Epub 2013 Apr 11.
8
Association of Age-Related Macular Degeneration With Risk of All-Cause and Specific-Cause Mortality in the National Health and Nutrition Examination Survey, 2005 to 2008.年龄相关性黄斑变性与 2005 至 2008 年全国健康和营养调查中全因和特定原因死亡率的关系。
JAMA Ophthalmol. 2019 Mar 1;137(3):248-257. doi: 10.1001/jamaophthalmol.2018.6150.
9
Early and intermediate age-related macular degeneration: update and clinical review.早、中期年龄相关性黄斑变性:最新进展与临床综述
Clin Interv Aging. 2017 Oct 3;12:1579-1587. doi: 10.2147/CIA.S142685. eCollection 2017.
10
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.膳食类胡萝卜素、维生素A、C和E与年龄相关性黄斑变性。眼病病例对照研究组。
JAMA. 1994 Nov 9;272(18):1413-20.

引用本文的文献

1
Identification of risk factors for the progression of age-related macular degeneration: a systematic review and meta-analysis of cohort studies.年龄相关性黄斑变性进展的危险因素识别:队列研究的系统评价与荟萃分析
Front Med (Lausanne). 2025 Jul 23;12:1544765. doi: 10.3389/fmed.2025.1544765. eCollection 2025.
2
Identification and validation of integrated stress-response-related genes as biomarkers for age-related macular degeneration.鉴定和验证整合应激反应相关基因作为年龄相关性黄斑变性的生物标志物
Front Mol Biosci. 2025 Jul 16;12:1583237. doi: 10.3389/fmolb.2025.1583237. eCollection 2025.
3
Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future Directions.

本文引用的文献

1
Statins for age-related macular degeneration.用于年龄相关性黄斑变性的他汀类药物。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD006927. doi: 10.1002/14651858.CD006927.pub5.
2
Lipids, oxidized lipids, oxidation-specific epitopes, and Age-related Macular Degeneration.脂质、氧化脂质、氧化特异性表位与年龄相关性黄斑变性。
Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Apr;1862(4):430-440. doi: 10.1016/j.bbalip.2016.07.013. Epub 2016 Jul 30.
3
Genetics and age-related macular degeneration: a practical review for the clinician.
视网膜疾病的精准治疗与基因治疗应用进展:影响与未来方向
Genes (Basel). 2025 Jul 21;16(7):847. doi: 10.3390/genes16070847.
4
Functional and Anatomical Outcomes of Faricimab in Previously Treated Wet Age-Related Macular Degeneration: Systematic Review and Pooled Analysis.法西单抗治疗既往治疗过的湿性年龄相关性黄斑变性的功能和解剖学转归:系统评价与汇总分析
Ophthalmol Ther. 2025 Jul 3. doi: 10.1007/s40123-025-01181-4.
5
MSLI-Net: retinal disease detection network based on multi-segment localization and multi-scale interaction.MSLI-Net:基于多段定位和多尺度交互的视网膜疾病检测网络。
Front Cell Dev Biol. 2025 Jun 6;13:1608325. doi: 10.3389/fcell.2025.1608325. eCollection 2025.
6
Sustainable Practices in Anti-VEGF Therapy: A 15-Year Bibliometric Analysis of Ranibizumab for Age-Related Macular Degeneration.抗VEGF治疗的可持续实践:雷珠单抗治疗年龄相关性黄斑变性的15年文献计量分析
J Ophthalmol. 2025 May 6;2025:8891531. doi: 10.1155/joph/8891531. eCollection 2025.
7
Neuroprotection provided by polyphenols and flavonoids in photoreceptor degenerative diseases.多酚和黄酮类化合物在光感受器退行性疾病中的神经保护作用。
Neural Regen Res. 2026 Mar 1;21(3):908-922. doi: 10.4103/NRR.NRR-D-24-01638. Epub 2025 May 6.
8
Phlorizin Protects Against Oxidative Stress and Inflammation in Age-Related Macular Degeneration Model.根皮苷对年龄相关性黄斑变性模型中的氧化应激和炎症具有保护作用。
Biomolecules. 2025 Apr 3;15(4):523. doi: 10.3390/biom15040523.
9
Ferroptosis: An Energetic Villain of Age-Related Macular Degeneration.铁死亡:年龄相关性黄斑变性的一个“能量反派”
Biomedicines. 2025 Apr 17;13(4):986. doi: 10.3390/biomedicines13040986.
10
Exploring the Causal Relationships between Lipid Biomarkers and Anti-VEGF Treatment Response in Patients with Neovascular Age-related Macular Degeneration.探索新生血管性年龄相关性黄斑变性患者脂质生物标志物与抗VEGF治疗反应之间的因果关系。
Ophthalmol Sci. 2025 Jan 13;5(4):100711. doi: 10.1016/j.xops.2025.100711. eCollection 2025 Jul-Aug.
遗传学与年龄相关性黄斑变性:临床医生实用综述
Clin Ophthalmol. 2016 Jul 4;10:1229-35. doi: 10.2147/OPTH.S109723. eCollection 2016.
4
Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.评估年龄相关性黄斑变性的年龄相关性眼病研究分级量表的有效性:年龄相关性眼病研究2(AREDS2)报告10
JAMA Ophthalmol. 2016 Sep 1;134(9):1041-7. doi: 10.1001/jamaophthalmol.2016.2383.
5
A Revised Hemodynamic Theory of Age-Related Macular Degeneration.年龄相关性黄斑变性的修正血流动力学理论
Trends Mol Med. 2016 Aug;22(8):656-670. doi: 10.1016/j.molmed.2016.06.009. Epub 2016 Jul 13.
6
AMD and the alternative complement pathway: genetics and functional implications.年龄相关性黄斑变性与替代补体途径:遗传学及功能意义
Hum Genomics. 2016 Jun 21;10(1):23. doi: 10.1186/s40246-016-0079-x.
7
Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes.鉴别玻璃膜疣:与年龄相关的玻璃膜疣和类似玻璃膜疣的外观、年龄相关性黄斑变性、遗传性眼病和其他病理过程有关。
Prog Retin Eye Res. 2016 Jul;53:70-106. doi: 10.1016/j.preteyeres.2016.04.008. Epub 2016 May 10.
8
Risk factors and biomarkers of age-related macular degeneration.年龄相关性黄斑变性的危险因素和生物标志物。
Prog Retin Eye Res. 2016 Sep;54:64-102. doi: 10.1016/j.preteyeres.2016.04.003. Epub 2016 May 6.
9
Overview of Risk Factors for Age-Related Macular Degeneration (AMD).年龄相关性黄斑变性(AMD)的危险因素概述
J Stem Cells. 2015;10(3):171-91.
10
Regression of Some High-risk Features of Age-related Macular Degeneration (AMD) in Patients Receiving Intensive Statin Treatment.他汀类药物强化治疗对年龄相关性黄斑变性(AMD)高危特征的消退作用。
EBioMedicine. 2016 Feb 4;5:198-203. doi: 10.1016/j.ebiom.2016.01.033. eCollection 2016 Mar.